Cengild Medical Berhad, an investment holding company, engages in the operation of medical centers in Malaysia. The company provides various care and treatment consultant services for gastrointestinal and liver diseases, morbid obesity, and oncology and urological conditions; and general cardiology and gynecology assessment, gastroenterology, and hepatology, as well as gastrointestinal surgeries, including upper gastrointestinal, hepatobiliary, pancreatic, colorectal surgery, and bariatric surgery. It also provides medical management services, such as nursing services and clinical support services comprising radiology for advanced imaging, pharmacy for precise medication management, clinical laboratory for diagnostic tests, dietetics and nutrition expertise, physiotherapy for rehabilitation, and meticulous medical record services. The company was founded in 2017 and is based in Kuala Lumpur, Malaysia.
Stock data | 2023 | Change |
---|---|---|
Price | $0.0636192271442036 | N/A |
Market Cap | $52.12M | N/A |
Shares Outstanding | 819.27M | 27.14% |
Employees | 130.00 | N/A |
Shareholder Equity | 106.11M | 14.16% |
Valuation | 2023 | Change |
---|---|---|
P/E Ratio | 3.95 | N/A |
P/S Ratio | 3.15 | N/A |
P/B Ratio | 0.49 | N/A |
Growth | 2023 | Change |
---|---|---|
Return on Equity | 0.0295 | N/A |
Earnings | 2023 | Change |
---|---|---|
Revenue | $16.56M | N/A |
Earnings | $3.13M | N/A |
EPS | 0.0161 | N/A |
Earnings Yield | 0.2531 | N/A |
Gross Margin | 0.4372 | N/A |
Operating Margin | 0.2061 | N/A |
Net income margin | 0.1891 | N/A |
Financial Strength | 2023 | Change |
---|---|---|
Total Assets | $31.04M | N/A |
Total Debt | $3.52M | N/A |
Cash on Hand | $23.16M | N/A |
Debt to Equity | 0.0569 | -15.61% |
Cash to Debt | $6.58 | 23.49% |
Current Ratio | $9.32 | 15.90% |